Year archive

Saniona — 2025 filings

All 40 regulatory filings released by Saniona (SANION) in 2025, sourced directly from the official regulator.

40 Filings

2025 Period

2025 filings (40)

Filing	Released	Lang
Interim / Quarterly Report 2025 Interim / Quarterly Report 9M 2025	2025-11-27	Swedish
Interim / Quarterly Report 2025 Interim / Quarterly Report Q3 2025	2025-11-27	English
Saniona väljer SAN2668 som först-i-klassen klinisk kandidat för pediatrisk epilepsi Regulatory Filings	2025-09-04	Swedish
Saniona selects SAN2668 as first-in-class clinical candidate for paediatric epilepsy Regulatory Filings	2025-09-04	English
Interim / Quarterly Report 2025 Interim / Quarterly Report Q2 2025	2025-08-28	Swedish
Interim / Quarterly Report 2025 Interim / Quarterly Report H1 2025	2025-08-28	English
Saniona ingår exklusivt licensavtal med Jazz Pharmaceuticals för att utveckla och kommersialisera SAN2355 M&A Activity	2025-08-20	Swedish
Saniona Enters Exclusive Licensing Agreement with Jazz Pharmaceuticals to Develop and Commercialize SAN2355 M&A Activity	2025-08-20	English
Ändring av antalet aktier och röster i Saniona AB Share Issue/Capital Change	2025-07-31	Swedish
Change in number of shares and votes in Saniona AB Share Issue/Capital Change	2025-07-31	English
Fenja Capital II A/S requests conversion of the remaining outstanding convertibles for a total nominal amount of SEK 6 million Capital/Financing Update	2025-06-26	English
Fenja Capital II A/S påkallar konvertering av resterande utestående konvertibler med ett totalt nominellt belopp om 6 MSEK Capital/Financing Update	2025-06-26	Swedish
Kommuniké från årsstämma den 28 maj 2025 i Saniona AB AGM Information	2025-05-28	Swedish
Bulletin from the Saniona AB annual shareholders’ meeting on May 28, 2025 AGM Information	2025-05-28	English
Earnings Release 2025 Earnings Release Q1 2025	2025-05-28	Swedish
Investor Presentation 2025 Investor Presentation	2025-05-28	English
Saniona utser Johnny Stilou till Chief Financial Officer Board/Management Information	2025-05-12	Swedish
Saniona appoints Johnny Stilou as Chief Financial Officer Board/Management Information	2025-05-12	English
Annual Report (ESEF) 2024 Annual Report (ESEF) FY 2024	2025-04-30	Swedish
Ändring av antalet aktier och röster i Saniona AB Declaration of Voting Results & Voting Rights Announcements	2025-04-30	Swedish
Change in number of shares and votes in Saniona AB Declaration of Voting Results & Voting Rights Announcements	2025-04-30	English
Notice of Saniona AB annual shareholders’ meeting AGM Information	2025-04-25	English
Kallelse till årsstämma i Saniona AB AGM Information	2025-04-25	Swedish
Major Shareholding Notification 2025 Major Shareholding Notification	2025-04-17	Swedish
Saniona announces preliminary outcome of exercise of warrants series TO 4 Capital/Financing Update	2025-04-02	English
Saniona meddelar preliminärt utfall för nyttjandet av teckningsoptioner serie TO 4 Share Issue/Capital Change	2025-04-02	Swedish
Declaration of Voting Results & Voting Rights Announcements 2025 Declaration of Voting Results & Voting Rights Announcements	2025-03-05	Swedish
Acadia Pharmaceuticals och Saniona meddelar initiala positiva resultat från fas 1-studien med ACP-711 (tidigare SAN711) Legal Proceedings Report	2025-03-03	Swedish
Acadia Pharmaceuticals and Saniona Announce Initial Positive Results from ACP-711 (formerly SAN711) Phase 1 Study Legal Proceedings Report	2025-03-03	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-03-03	Swedish
Interim / Quarterly Report 2024 Interim / Quarterly Report Q4 2024	2025-02-27	Swedish
Audit Report / Information 2024 Audit Report / Information FY 2024	2025-02-27	English
Medix has resubmitted tesofensine application to COFEPRIS Legal Proceedings Report	2025-02-20	English
Medix har skickat in ansökan för tesofensine till COFEPRIS igen Regulatory Filings	2025-02-20	Swedish
Medix to submit final version of tesofensine application following interaction with COFEPRIS Regulatory Filings	2025-02-10	English
Medix kommer att lämna in slutgiltig ansökan för tesofensin efter interaktion med COFEPRIS. Regulatory Filings	2025-02-10	Swedish
Saniona’s Nomination Committee Proposes John Haurum as New Chairman of the Board of Directors Board/Management Information	2025-01-10	English
Sanionas valberedning föreslår John Haurum till ny styrelseordförande Board/Management Information	2025-01-10	Swedish
Saniona’s Nomination Committee Proposes John Haurum as New Chairman of the Board of Directors Board/Management Information	2025-01-10	English
Sanionas valberedning föreslår John Haurum till ny styrelseordförande Board/Management Information	2025-01-10	Swedish